Replies to post #133757 on Biotech Values

[DewDiligence]

Ok - agree that is good estimate. It is what I was using in general for branded biologics. Now the other assumption? (What would be a fair split of Gross Profit for mHumira)

That’s yesterday’s query, not today’s. Now that an FoB deal has actually been struck, what I need to ascertain is how much economic value MNTA will garner from the partnership. Whether BAX got the better of MNTA, MNTA got the better of BAX, or the deal was exactly fair in every respect is no longer of great consequence to me as a MNTA investor.